Medtronic Manipulated Bone Device Studies, Report Says

Law360, New York (October 25, 2012, 2:12 PM EDT) -- Medical device maker Medtronic Inc. may have manipulated company-sponsored health studies of its Infuse bone-growth product by editing the published content and paying doctors and researchers $210 million over 15 years for favorable reviews, according to a U.S. Senate Finance Committee report released Thursday.

The report, which was the result of a 16-month investigation into Medtronic, revealed questionable ties between the medical technology giant and the physician consultants who tested and reviewed its products, said Senate Finance Committee Chairman Max Baucus, D-Mont., and Sen. Chuck Grassley,...
To view the full article, register now.